Company Profile
Jubilant Pharmova is an integrated pharmaceutical company globally. Its business is organized into six segments: Radiopharma. Its portfolio also includes Allergy Immunotherapy, Contract Development and Manufacturing Organisation - Sterile Injectables, Generics, Contract Research Development and Manufacturing Organisation, and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of various diseases
Including pulmonary embolism, cancer, coronary artery disease, and others. Its Allergy Immunotherapy segment provides specialised diagnostic devices for skin testing, as well as venom and allergy immunotherapy products.
The Contract Development and Manufacturing Organisation - Sterile Injectables segment offers contract manufacturing services for sterile fill and finish injectables, liquids, ointments, creams, and ampoules.
Its Generics segment engages in the development, manufacturing, distribution, sale, and marketing of generic formulations for therapeutic areas comprising cardiovascular system, central nervous system, gastrointestinal, antibiotics, and multispecialty. The Contract Research Development and Manufacturing Organisation segment offers drug discovery services and active pharmaceutical ingredients.
The Proprietary Novel Drugs segment provides patient-focused biopharmaceutical services to address unmet medical needs in oncology and autoimmune diseases. The company serves pharmaceutical, biotech, group purchasing organisations, allergists, and hospitals sectors.
It sells its products through a network of dealers and distributors. Formerly known as Jubilant Life Sciences Limited, the company rebranded as Jubilant Pharmova Limited in February 2021. The company was incorporated in 1978 and is based in Noida, India.